Page last updated: 2024-08-23

vindesine and Recrudescence

vindesine has been researched along with Recrudescence in 32 studies

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19905 (15.63)18.7374
1990's11 (34.38)18.2507
2000's11 (34.38)29.6817
2010's4 (12.50)24.3611
2020's1 (3.13)2.80

Authors

AuthorsStudies
Chen, FF; Cui, L; Huang, XT; Li, ZG; Lian, HY; Ma, HH; Wang, CJ; Wang, D; Wang, TY; Wei, A; Yang, Y; Zhang, L; Zhang, Q; Zhang, R; Zhu, T1
Brion, A; Chabin, M; Clavert, A; Colombat, P; Cumin, I; Delwail, V; Escoffre-Barbe, M; Gardembas, M; Ingrand, P; Lacotte-Thierry, L; Legouffe, E; Olivier, G; Solal-Celigny, P1
Feng, G; Huang, XL; Wan, H; Wang, F; Wang, XJ1
Gao, XN; Guo, YL; Han, XP; Jin, XS; Jing, Y; Liu, K; Yao, ZL; Yu, L; Zhang, R1
Cai, HC; Cao, XX; Chen, M; Duan, MH; Han, B; Han, X; Li, J; Wang, SJ; Yang, C; Zhang, W; Zhou, DB; Zhu, TN; Zhuang, JL1
Egberts, F; Hauschild, A; Hitschler, WN; Weichenthal, M1
Corbacioglu, S; Eber, S; Gungor, T; Hummerjohann, J; Niggli, F1
Hinkelbein, W; Hoecht, S1
Adli, M; Kalender, ME; Sevinc, A1
Brunot, A; Issler, M; Ojeda-Uribe, M1
Dibar, E; Eppinger-Helft, M; Garay, G; Kvicala, R; Milone, J; Montres Varela, D; Pavlovsky, S; Sackmann Muriel, F1
Akabane, T; Hara, T; Koike, K; Komiyama, A; Tsukada, M1
Conter, V; Jankovic, M; Locasciulli, A; Masera, G; Rossi, MR; Uderzo, C1
Coiffier, B; Farcet, JP; Gabarre, J; Gastaldi, R; Gisselbrecht, C; Lepage, E; Oksenhendler, E; Raphael, M; Thyss, A; Tirelli, U1
Kleisbauer, JP; Le Caer, H; Montcharmont, D; Pradal, M; Thomas, P; Vervloet, D1
Audhuy, B; Blanc, M; Brière, J; Coiffier, B; Diviné, M; Dupriez, B; Herbrecht, R; Lederlin, P; Lepage, E; Mineur, P; Pautier, P; Reyes, F; Tilly, H1
Ohnishi, K; Ohno, R; Shinjyo, K; Takeshita, A; Tobita, T; Yanagi, M1
Ariyoshi, Y; Fukuoka, M; Furuse, K; Katagami, N; Kawahara, M; Kudoh, S; Nishikawa, H; Takada, Y1
Manoharan, A1
Cazals-Hatem, D; Chevret, S; Clauvel, JP; Dubreuil, ML; Gerard, L; Levy, Y; Matheron, S; Oksenhendler, E1
Eguchi, K; Harada, M; Kiura, K; Miyamoto, H; Segawa, Y; Shibayama, T; Tabata, M; Takata, I; Takigawa, N; Ueoka, H1
Daibata, M; Hatakeyama, N; Hiroi, M; Kamioka, M; Miyoshi, I; Nemoto, Y; Taguchi, H1
Fujitaka, K; Isobe, T; Kagawa, K; Kohno, N; Miyazaki, M; Oguri, T; Yamasaki, M1
Bilhou-Nabera, C; Boiron, JM; Bouabdallah, R; Boucheix, C; Cazin, B; Charrin, C; Delannoy, A; Dombret, H; Fière, D; Huguet, F; Lhéritier, V; Sebban, C; Straetmans, N; Thomas, X; Vernant, JP; Zérazhi, H1
Andrien, F; Auzanneau, G; Bosly, A; Coiffier, B; Devaux, Y; Gisselbrecht, C; Herbrecht, R; Jaubert, J; Legros, M; Tilly, H1
Chisa, M; Hasegawa, S; Katoh, M; Koike, M; Kubomatsu, Y; Kunika, N; Nakamura, K; Sano, F; Takahashi, M; Wakayama, T1
Bancillon, A; Baruchel, A; Bergeron, C; Leblanc, T; Lejars, O; Lepage, E; Leverger, G; Perel, Y; Schaison, G; Sommelet, D1
Oguro, M; Sakai, C; Takagi, T1
Diedrich, H; Freund, M; Ganser, A; Gramatzki, M; Haas, R; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Kuse, R1
Armand, JP; Benhamed, M; Cvitkovic, E; Domenge, C; Guillot, T; Izzo, J; Recondo, G; Tellez-Bernal, E1
Kano, Y; Masaoka, T; Mikuni, C; Sakamoto, S; Sampi, K; Takagi, T1
Akagi, K; Asou, N; Goto, J; Hamasaki, N; Hidaka, M; Kawano, F; Kurisaki, H; Sawatari, T; Suzushima, H; Takatsuki, K1

Trials

10 trial(s) available for vindesine and Recrudescence

ArticleYear
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
    American journal of hematology, 2014, Volume: 89, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Immunocompetence; Infections; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Palliative Care; Prednisolone; Recurrence; Remission Induction; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Vindesine

2014
Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse.
    Melanoma research, 2009, Volume: 19, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; L-Lactate Dehydrogenase; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Nerve Growth Factors; Prospective Studies; Recombinant Proteins; Recurrence; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Vindesine

2009
Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
    Cancer chemotherapy and pharmacology, 1983, Volume: 10, Issue:3

    Topics: Adolescent; Adult; Anemia; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Leukopenia; Prednisone; Prognosis; Recurrence; Vinblastine; Vindesine

1983
Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.
    The American journal of medicine, 1993, Volume: 95, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; HIV Seropositivity; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Prednisolone; Prospective Studies; Recurrence; Remission Induction; Survival Rate; Vindesine

1993
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Prospective Studies; Recurrence; Survival Analysis; Vindesine

1999
Gentle yet effective treatment for elderly patients with refractory or relapsing multiple myeloma.
    American journal of hematology, 2000, Volume: 65, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Male; Melphalan; Multiple Myeloma; Prednisolone; Recurrence; Treatment Outcome; Vincristine; Vindesine

2000
Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 2000, Volume: 46, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Recurrence; Survival Analysis; Vindesine

2000
Treatment of acute lymphoblastic leukemia in the elderly: an evaluation of interferon alpha given as a single agent after complete remission.
    Leukemia & lymphoma, 2002, Volume: 43, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Humans; Interferon-alpha; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Random Allocation; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine; Vindesine

2002
Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Female; France; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Risk Factors; Vincristine; Vindesine

1992
[Aclarubicin-combined combination chemotherapy in patients with refractory or relapsed non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:1

    Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multicenter Studies as Topic; Prednisolone; Recurrence; Remission Induction; T-Lymphocytes; Vinblastine; Vindesine

1989

Other Studies

22 other study(ies) available for vindesine and Recrudescence

ArticleYear
Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH-LCH 2014 protocol study.
    American journal of hematology, 2023, Volume: 98, Issue:4

    Topics: Child; Child, Preschool; Cladribine; Histiocytosis, Langerhans-Cell; Humans; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Vindesine

2023
[Clinical Efficacy of Bleomycin, Cyclophosphamide, Vindesine, Ara-C and Dexamethasone for Treatment of Patients with Relapsed Refractory Diffuse Large B Cell Lymphoma].
    Zhongguo shi yan xue ye xue za zhi, 2015, Volume: 23, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Recurrence; Treatment Outcome; Vincristine; Vindesine

2015
[Imatinib Combined with VP Low Dose Regiment for Treating Newly Diagnosed Adult Patients with Ph-positive ALL].
    Zhongguo shi yan xue ye xue za zhi, 2015, Volume: 23, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Induction Chemotherapy; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Recurrence; Remission Induction; Transplantation, Homologous; Vindesine

2015
Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study.
    Leukemia research, 2016, Volume: 42

    Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome; Vindesine; Young Adult

2016
Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Burkitt Lymphoma; Child; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Humans; Immunotherapy; Leukemic Infiltration; Male; Meninges; Methotrexate; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Testis; Topotecan; Transplantation, Autologous; Vindesine

2003
Treatment of localized lymphoma.
    The New England journal of medicine, 2005, Jun-09, Volume: 352, Issue:23

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Survival Analysis; Vincristine; Vindesine

2005
Treatment of localized lymphoma.
    The New England journal of medicine, 2005, Jun-09, Volume: 352, Issue:23

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Vincristine; Vindesine

2005
[Successful treatment of idiopathic acquired refractory thrombotic thrombocytopenic purpura with an association of rituximab-vindesine. Report of one case].
    Revista medica de Chile, 2005, Volume: 133, Issue:11

    Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Purpura, Thrombotic Thrombocytopenic; Recurrence; Rituximab; Treatment Outcome; Vindesine; von Willebrand Factor

2005
[Vindesine plus L-asparaginase and prednisolone therapy (VDS-VLP therapy) for remission induction in children with relapsed acute lymphoblastic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1983, Volume: 24, Issue:5

    Topics: Adolescent; Antineoplastic Agents, Phytogenic; Asparaginase; Child; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Male; Prednisolone; Recurrence; Vinblastine; Vindesine

1983
[Preliminary data on treatment with Vindesine in relapses of acute lymphoblastic leukemia].
    Haematologica, 1981, Volume: 66, Issue:5

    Topics: Child; Humans; Leukemia, Lymphoid; Recurrence; Vinblastine; Vindesine

1981
[Acute bronchospasm due to periwinkle alkaloid and mitomycin association].
    Revue des maladies respiratoires, 1993, Volume: 10, Issue:3

    Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Bronchial Spasm; Bronchodilator Agents; Humans; Middle Aged; Mitomycins; Recurrence; Respiration, Artificial; Spirometry; Vindesine

1993
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Vindesine

1996
Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid.
    Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:7

    Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cytarabine; Daunorubicin; Ear Canal; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Mercaptopurine; Middle Aged; Mitoxantrone; Neoplasm Proteins; Oncogene Proteins, Fusion; Radiotherapy; Recurrence; Remission Induction; Salvage Therapy; Tretinoin; Vindesine

1997
Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 2000, Volume: 39, Issue:1-2

    Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Treatment Outcome; Vindesine

2000
Detection of human herpesvirus 6 and JC virus in progressive multifocal leukoencephalopathy complicating follicular lymphoma.
    American journal of hematology, 2001, Volume: 67, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain; Cyclophosphamide; DNA, Viral; Doxorubicin; Etoposide; Fatal Outcome; Female; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Immunity, Cellular; Immunocompromised Host; JC Virus; Leukoencephalopathy, Progressive Multifocal; Lymphoma, Follicular; Magnetic Resonance Imaging; Mitoxantrone; Nitrosourea Compounds; Papillomavirus Infections; Piperazines; Polymerase Chain Reaction; Prednisolone; Recurrence; Salvage Therapy; Vincristine; Vindesine; Virus Activation

2001
Syndrome of inappropriate secretion of ADH (SIADH) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion.
    Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:10

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Female; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Recurrence; Time Factors; Vindesine

2001
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma; Male; Middle Aged; Multivariate Analysis; Prednisolone; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Survival Analysis; Vindesine

1992
[Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:14

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Rate; Vindesine

1992
[Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Recurrence; Vincristine; Vindesine

1992
Treatment of relapsed or refractory adult acute lymphocytic leukemia.
    Cancer, 1992, Feb-01, Volume: 69, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Vindesine

1992
A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer.
    Cancer, 1990, Aug-15, Volume: 66, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Leukocyte Count; Male; Middle Aged; Neutropenia; Recurrence; Remission Induction; Survival Rate; Vindesine

1990
["AB-Triple V" therapy of relapsed or refractory acute myelogenous leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:2

    Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction; Vinblastine; Vincristine; Vindesine

1989